期刊
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
卷 21, 期 7, 页码 1781-+出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2022.09.026
关键词
Pancreatitis; PROMIS; Depression; Anxiety; Sleep disturbance; Pancreas
This study analyzed baseline data of 488 patients with chronic pancreatitis (CP) and 254 control subjects, and found that pain was significantly associated with impairments in physical and mental health. CP patients with severe pain had more decrements in each PROMIS domain and a higher prevalence of clinically significant depression, anxiety, sleep disturbance, and physical disability. Similar results were noted for constant pain.
METHODS: We analyzed baseline data in 488 CP patients and 254 control subjects enrolled in PROCEED (Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies), an ongoing longitudinal cohort study. Participants completed the PROMIS-Global Health, which captures global physical and mental health, and the PROMIS-29 profile, which captures 7 symptom domains. Self-reported pain was categorized by severity (none, mild-moderate, se-vere) and temporal nature (none, intermittent, constant). Demographic and clinical data were obtained from the PROCEED database.RESULTS: Pain was significantly associated with impairments in physical and mental health. Compared with participants with no pain, CP participants with severe pain (but not mild-moderate pain) had more decrements in each PROMIS domain in multivariable models (effect sizes, 2.54-7.03) and had a higher prevalence of clinically significant depression, anxiety, sleep disturbance, and physical disability (odds ratios, 2.11-4.74). Similar results were noted for constant pain (but not intermittent pain) for PROMIS domains (effect sizes, 4.08-10.37) and clinically significant depression, anxiety, sleep disturbance and physical disability (odds ratios, 2.80-5.38). CONCLUSIONS: Severe and constant pain are major drivers for poor psychological and physical health in CP. Systematic evaluation and management of psychiatric comorbidities and sleep disturbance should be incorporated into routine management of patients with CP. (ClinicalTrials.gov, Number: NCT03099850).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据